IDEV Announces Positive Two-Year Clinical Outcomes from Long Term Registry of the SUPERA® Stent in Femoropopliteal Artery Disease

IDEV Announces Positive Two-Year Clinical Outcomes from Long Term Registry of the SUPERA® Stent in Femoropopliteal Artery Disease PR Newswire LAS VEGAS and WEBSTER, Texas, Oct. 11, 2012 -- SUPERA 500 Data Presented at Vascular InterVentional Advances (VIVA) 2012 Conference in Las Vegas – LAS VEGAS and WEBSTER, Texas, Oct.